Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
367M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
24.5M
-
Shares change
-
-134K
-
Total reported value, excl. options
-
$753M
-
Value change
-
-$30M
-
Number of buys
-
25
-
Number of sells
-
-52
-
Price
-
$30.87
Significant Holders of Legend Biotech Corp - COMMON STOCK (LEGN) as of Q3 2020
85 filings reported holding LEGN - Legend Biotech Corp - COMMON STOCK as of Q3 2020.
Legend Biotech Corp - COMMON STOCK (LEGN) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.5M shares
of 367M outstanding shares and own 6.66% of the company stock.
Largest 10 shareholders include Vivo Capital, LLC (3.33M shares), Hudson Bay Capital Management LP (2.83M shares), RA CAPITAL MANAGEMENT, L.P. (2.41M shares), CAPITAL INTERNATIONAL INC (2.02M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.73M shares), Johnson & Johnson Innovation - JJDC, Inc. (1.63M shares), ALLIANCEBERNSTEIN L.P. (1.38M shares), FEDERATED HERMES, INC. (1.07M shares), FRANKLIN RESOURCES INC (1.03M shares), and Capital World Investors (1.02M shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.